Fact CheckerSign in

NCT04546126RecruitingEarly phase 1

Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)

Source: ClinicalTrials.gov · Last updated 5 Dec 2025

Brief summary (registry, in English)

This study will evaluate the feasibility of using a sub-therapeutic dose of a fluorine-18 analogue of NP-59 (\[18F\]FNP-59) to image the adrenal gland. Some participants are healthy normal subjects but have undergone interventions to manipulate hormones while other participants have known adrenal pathology.

Status (registry)
Recruiting
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
24 (estimated)
First submitted
8 Sept 2020
Start date
1 Nov 2021
Primary completion date
31 Dec 2026
Lead sponsor
Benjamin Viglianti
NCT number
NCT04546126

What you commit to

  • Study type: Interventional · Early phase 1
  • Planned participants: 24
  • From 1 Nov 2021 to the primary completion date, 31 Dec 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current use of steroids, Oral contraceptives (OCP), spironolactone, estrogen, androgen, progesterone, Angiotensin-converting enzyme (ACE inhibitors)/ Angiotensin II receptor blockers (ARBs), or supplements that are hormone analogues.

Other

  • Pregnancy
  • Unable to do imaging
  • Body weight greater than 400 lbs (181 Kg)
  • Prisoners are not eligible
  • Subjects unable to provide own consent are not eligible
  • Known adrenal pathology
  • Pregnant

Who the study is looking for

  • Participants without any known adrenal pathology as normal controls for undergoing endocrine manipulation
  • Abnormal adrenal cortical hormone secretion

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Michigan
Coordinator of this site? Confirm its status
Ann ArborUnited StatesRecruiting
BAMF Health Inc.
Coordinator of this site? Confirm its status
Grand RapidsUnited StatesCompleted

This page is information, not medical advice. Discuss any trial with your doctor.